Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
Published Online: 2017-06-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alessandro Gronchi•Angelo Paolo Dei Tos•Antonio Lopez Pousa•Carlo Morosi•Davide Maria Donati•Domenico Franco Merlo•Elena Palassini•Emanuela Marchesi•Emanuela Palmerini•Giovanni Grignani•Iwona Lugowska•Javier Martin Broto•Jean Michelle Coindre•Jean-Yves Blay•Oscar Tendero•Paolo Bruzzi•Paolo Giovanni Casali•Piero Picci•Rita De Sanctis•Robert Diaz Beveridge•Silvia Bagué•Silvia Stacchiotti•Stefano Ferrari•Umberto Basso•Valeria Fontana•Virginia Ferraresi•Vittorio Quagliuolo
